| NDC Code | 63379-059-02 |
|---|
| Package Description | 1 TRAY in 1 CARTON (63379-059-02) > 1 INHALER in 1 TRAY > 14 POWDER in 1 INHALER |
|---|
| Product NDC | 63379-059 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Breo Ellipta |
|---|
| Non-Proprietary Name | Fluticasone Furoate And Vilanterol Trifenatate |
|---|
| Dosage Form | POWDER |
|---|
| Usage | RESPIRATORY (INHALATION) |
|---|
| Start Marketing Date | 20150430 |
|---|
| Marketing Category Name | APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT |
|---|
| Application Number | NDA204275 |
|---|
| Manufacturer | Glaxo Operations UK Ltd |
|---|
| Substance Name | FLUTICASONE FUROATE; VILANTEROL TRIFENATATE |
|---|
| Strength | 200; 25 |
|---|
| Strength Unit | ug/1; ug/1 |
|---|
| Pharmacy Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
|---|